I-Antiretroviral Therapy
I-PART yesikhalazo imele i-antiretroviral therapy. Oku kubhekisela kudibaniso lweziyobisi ezisetyenziselwa ukugcina iintsholongwane ze- HIV phantsi kolawulo. Ezi zibizwa ngokuba zibizwa ngokuba yi- HAART kunye negama lesi sigama sele liqhubekele phambili kwi-ART kuphela kwi-antiretroviral therapy.
Ukuhlanganiswa kwezidakamizwa ezisetyenzisiweyo kwikharityhulam kubandakanya ubuncinci bamayeza asebenzayo amabini avela kwiiklasi ezimbini.
Ngokuqhelekileyo ziqulethe izidakamizwa ezintathu okanye ezahlukeneyo. Ukusebenzisa udibaniso lwezilwanyana ezahlukeneyo lenza unyango luphumelele. Kwakhona kunciphisa umngcipheko wokuba isigulane sinakho ukuvelisa ukunganyanga kweziyobisi.
Iiklasi eziphambili zonyango eziqhelekileyo ezibandakanyiweyo kwiirityhulam ziquka:
- I-Nucleotide reverse transcriptase inhibitors (i-NRTIs)
- I-non-nucleotide reverse transcriptase inhibitors (i-NNRTIs)
- Protease inhibitors (i-PIs)
- Integrase inhibitors
Uhlobo ngalunye lweziyobisi luphazamisa izigaba ezahlukeneyo zokusuleleka kwe-HIV kunye nokuphindaphinda.
Kutheni i-ART kunye nekhadi libuyisela i-HAART?
I- HAART (i-antiretroviral ye-anti-antiretroviral esebenzayo) isetyenziswe iminyaka emininzi. Kudideka ukubona itekethi okanye i-ART isetyenziswe endaweni yoko. Kutheni ezinye iinzululwazi ziqala ukuhamba ukusuka kwi- HAART yekota? Njengoko kuvela, kukho isizathu esona sitshintsho. I-PART yindlela yonyango ukuba oogqirha baxelele ukusetyenziswa kwemida ye-antiretroviral kwixesha apho kunomdla okhulayo kwi-monotherapies.
I-Monotherapies ziyodwa zonyango zonyango lwe-HIV / AIDS.
Nangona i-HAART yonyango iququzelelwe ngokudibeneyo, eli gama linokusetyenziswa kwakhona ukubhekisela kwi-monotherapy esebenzayo. Ukubhekiselele ngqo kwiCART kuvumela oogqirha ukuba bahluke ngokucacileyo phakathi kweenkcazo zokusetyenziswa kweziyobisi kunye namayeza athile.
Ngokwahlukileyo, ukusebenzisa i-HAART yekota idibana namanqanaba olwazi lwezonyango. Uvumelekile ukuba ubone itekisi esetyenziswa kwiincwadi emva ko-2009.
Isinyathelo esilandelayo kwakukutshintshela kwi-ART njengegama eliqhelekileyo, nangona lithetha ukuba kusetyenziswe izidakamizwa ezintathu okanye ngaphezulu ze-antiretroviral, ezinokuthi zithathwe ngokwawo okanye ngokuhlanganiswa kokuhlanganisana.
I-Monotherapies kunye neMpilo yokuHlanganisa
Inzala kwi-monotherapies ivela kwiminqweno yokunciphisa imingcipheko yokunyangwa kwe-HIV / AIDS. Ezi zithintelo ziquka iindleko zeziyobisi kunye nobunzima ngokuthatha iyeza njengoko kuchaziwe. Ukusetyenziswa kweziyobisi ezingaqhelekanga kungasetyenziselwa ukunciphisa ingozi yonyango lwexesha elide kunye neziyobisi ezahlukeneyo ze-HIV . Ngokomzekelo, bangasetyenziselwa ukujongana nemiphumo emibi efana nokuguga kwexesha elide kunye nokungasebenzi komzimba.
Iingxabano ngokubhekiselele ekusebenziseni i-monotherapies ziquka ukukhathazeka ukuba ukusebenzisa unyango olulodwa kunyusela kakhulu ingozi yokukhuthaza ukwenziwa kweentsholongwane ezingenakuxhatshazwa yi-virus. Kukho iinkxalabo zokuthi iirmimen zezilwanyana ezingekho mnye zingasayi kusebenza njengemigqaliselo.
Nangona kunjalo, kwanabo bavuma ukuba i-monotherapy ayinakunceda kuzo zonke izigulane ze-HIV zihlala zikulungele ukuvuma ukuba kulungelelaniswe kwimigangatho ethile.
Ngokomzekelo, i-monotherapy inokuba luncedo kubantu abanobuhle, ukukhutshwa kwexesha elide le-HIV basebenzise imithi yokudibanisa yemveli. Bakhombisile ukuba bangathabatha amayeza abo ngokufanayo. Bangafuna kwakhona imithi encinane yokugcina umthamo wentsholongwane.
ILizwi
Unokuqhubeka nokubona yonke imigaqo emithathu kwiincwadi nakwi-intanethi. Nangona kunokudideka iminyaka embalwa, igama elithi ART libandakanya iintlobo ezahlukeneyo zonyango olufanelekileyo lwe-HIV. Uza kubona i-ART isebenziselwa urhulumente wase-US kunye neZiko leMpilo yeNtshonalanga kunye nezipapasho.
> Umthombo:
> Unyango lwe-antiretroviral (ART). ISebe lezeMpilo laseMelika kunye neeNkonzo zoLuntu. https://aidsinfo.nih.gov/understanding-hiv-aids/glossary/883/antiretroviral-therapy/.